Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
TAK-242: TLR4 Inhibition Workflow Guide
2026-08-16
TAK-242 (Resatorvid) provides a focused way to dissect LPS-triggered inflammation, macrophage phagocytosis, and host–pathogen signaling. This guide connects dose planning and assay controls with the recent Salmonella haem study, while separating validated evidence from practical workflow recommendations.
-
Gramine: Reliable Ferroptosis Assay Workflows
2026-08-15
This scenario-based guide explains how Gramine (SKU N2337) can support reproducible viability, proliferation, and ferroptosis experiments in triple-negative breast cancer models. It connects published CUL3–MTDH findings with practical choices for stock preparation, controls, data interpretation, and product selection.
-
Visceral ATM-Targeted TACE Silencing in Obesity
2026-08-14
Yong, Song, and Kim developed an ATS-9R-based nonviral delivery strategy to silence TACE selectively in visceral adipose tissue macrophages. Their findings connect tissue-selective gene delivery with reduced adipose inflammation and improved obesity-induced type 2 diabetes, providing a useful framework for targeted metabolic disease research.
-
JC-1 Mitochondrial Membrane Potential Assay Workflow
2026-08-14
Build a ratiometric mitochondrial membrane potential assay around JC-1 to distinguish depolarization from simple changes in cell number or fluorescence intensity. This workflow combines CCCP controls, reproducible imaging or plate-reader acquisition, and troubleshooting guidance for apoptosis assay, cytotoxicity, and mitochondrial function analysis.
-
Spatially Patterned Kidney Assembloids for Disease Modeling
2026-08-13
Huang and colleagues developed mouse and human kidney progenitor assembloids that reproduce spatial relationships between nephron and collecting-system progenitors, improving tissue organization, maturation, and functional capacity. Their genome-edited PKD2-deficient assembloids also provide a higher-fidelity platform for studying polycystic kidney disease and interactions among cystic epithelium, stroma, and macrophages.
-
Single-Cell Basis of Ciprofloxacin–Tetracycline Antagonism
2026-08-13
The reference study shows that ciprofloxacin–tetracycline antagonism is driven primarily by improved survival under combination treatment rather than by a simple reduction in growth inhibition. Its microfluidic single-cell approach links nutrient-dependent initial growth, SOS-response heterogeneity, and bacterial cell death, providing a more resolved framework for interpreting antibiotic combinations.
-
MRE11 Lactylation and TNBC Radioresistance
2026-08-12
The reference study identifies lactate-dependent MRE11 Lys673 lactylation as a DNA-repair mechanism that supports radiotherapy resistance in triple-negative breast cancer. It further shows that Saikosaponin D activates an HIF1α/HDAC5 pathway to remove this modification, establishing a mechanistic link between tumor metabolism, epigenetic regulation, and radiation response.
-
Ciprofloxacin Hydrochloride at Single-Cell Scale
2026-08-12
Ciprofloxacin hydrochloride is a fluoroquinolone antibiotic whose effects depend on DNA damage, growth state, and cellular heterogeneity. This article translates single-cell evidence into practical assay design for antibiotic-interaction studies while distinguishing antibacterial, immunomodulatory, and translational claims.
-
Imatinib Hydrochloride: Kinase Research Guide
2026-08-11
Imatinib hydrochloride, also called STI571 hydrochloride, is a multi-target tyrosine kinase inhibitor for cancer research involving v-Abl, c-Kit, and PDGFR signaling. Its reported biochemical and cellular benchmarks support chronic myelogenous leukemia research and gastrointestinal stromal tumor research, but assay conditions and salt-form differences must be controlled.
-
HyperPFU™ high-fidelity DNA polymerase guide
2026-08-11
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It produces blunt-ended products for cloning and sequencing workflows, but it should not be selected when 3′-A overhangs or polymerase-generated sticky ends are required.
-
Captopril Workflows for ACE Inhibition Research
2026-08-10
Captopril provides a reproducible benchmark for ACE inhibition in hypertension research while enabling carefully controlled studies of bradykinin-linked gastrointestinal motility and apoptosis induction in cancer cells. This workflow-focused guide covers assay setup, solution handling, cross-domain applications, and troubleshooting for APExBIO product A4078.
-
BCECF: Ratiometric pH Sensing for Cell Studies
2026-08-09
BCECF is a membrane-impermeant, dual-excitation fluorescent pH probe for quantitative extracellular and accessible-compartment measurements. Its protonation-dependent intensity ratio supports pH analysis across approximately 6.0–8.0 and complements studies of ion transport, cellular metabolism, and microenvironmental pH regulation.
-
NAD+ and AMPK: Reading Cellular Energy Stress
2026-08-08
NAD+ is more than a redox cofactor: it helps researchers interpret how energy stress reshapes signaling, autophagy, and repair. This guide translates recent AMPK–ULK1 findings into practical NAD+ assay decisions using product-focused workflow design.
-
HOXC8, Caspase-1, and Lung Tumor Pyroptosis
2026-08-07
The reference study identifies HOXC8 as a suppressor of caspase-1-dependent pyroptosis in non-small cell lung carcinoma, linking transcriptional repression to tumor-cell survival. Its experiments indicate that HOXC8 recruits HDAC1/2 to the CASP1 promoter, while HOXC8 depletion increases caspase-1 abundance and slows tumor growth when targeted with cholesterol-conjugated siRNA.
-
Applied Cisplatin (CDDP) Workflows: From Xenografts to Resis
2026-08-07
Cisplatin (CDDP) remains the gold standard for dissecting DNA crosslinking-driven apoptosis and tumor growth inhibition in cancer research. This deep-dive article translates recent mechanistic advances into actionable workflows, troubleshooting strategies, and next-gen resistance studies, leveraging APExBIO’s trusted product.